| Date Filed | Type | Description |
| 06/08/2023 |
4
| CROWELL GAYLE A (Director) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 14,000 options to buy
@ $23.09, valued at
$323.3k
|
|
| 05/25/2023 |
4
| CROWELL GAYLE A (Director) has filed a Form 4 on Hercules Capital, Inc.|
Txns:
| Granted 218 shares
@ $13.09, valued at
$2.9k
Granted 865 shares
@ $13.87, valued at
$12k
|
|
| 05/09/2023 |
4
| CROWELL GAYLE A (Director) has filed a Form 4 on Hercules Capital, Inc.|
Txns:
| Bought 7,200 shares
@ $13.66, valued at
$98.4k
|
|
| 03/13/2023 |
4
| CROWELL GAYLE A (Director) has filed a Form 4 on Hercules Capital, Inc.|
Txns:
| Granted 187 shares
@ $15.32, valued at
$2.9k
Granted 755 shares
@ $15.33, valued at
$11.6k
|
|
| 03/02/2023 |
4
| CROWELL GAYLE A (Director) has filed a Form 4 on ENVESTNET, INC.|
Txns:
| Granted 3,208 shares
@ $0 |
|
| 11/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/01/2022 |
4
| CROWELL GAYLE A (Director) has filed a Form 4 on Hercules Capital, Inc.|
Txns:
| Granted 4,339 shares
@ $16.1318, valued at
$70k
|
|
| 06/21/2022 |
4
| CROWELL GAYLE A (Director) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 15,000 options to buy
@ $6.8, valued at
$102k
|
|
| 05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/18/2022 |
4
| CROWELL GAYLE A (Director) has filed a Form 4 on Hercules Capital, Inc.|
Txns:
| Granted 643 shares
@ $17.17, valued at
$11k
|
|
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/19/2021 |
4
| CROWELL GAYLE A (Director) has filed a Form 4 on Hercules Capital, Inc.|
Txns:
| Granted 521 shares
@ $17.33, valued at
$9k
|
|
| 08/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/02/2021 |
4
| CROWELL GAYLE A (Director) has filed a Form 4 on Hercules Capital, Inc.|
Txns:
| Granted 4,013 shares
@ $17.44, valued at
$70k
|
|
| 06/30/2021 |
4
| CROWELL GAYLE A (Director) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 13,286 options to buy
@ $28.2, valued at
$374.7k
|
|
| 06/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/18/2020 |
4
| CROWELL GAYLE A (Director) has filed a Form 4 on Hercules Capital, Inc.|
Txns:
| Granted 154 shares
@ $11.49, valued at
$1.8k
|
|
| 11/10/2020 |
4
| CROWELL GAYLE A (Director) has filed a Form 4 on Hercules Capital, Inc.|
Txns:
| Granted 4,379 shares
@ $11.4, valued at
$49.9k
|
|
| 08/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2020 |
3
| CROWELL GAYLE A (Director) has filed a Form 3 on PLIANT THERAPEUTICS, INC. |
| 05/26/2020 |
4
| CROWELL GAYLE A (Director) has filed a Form 4 on Hercules Capital, Inc.|
Txns:
| Granted 205 shares
@ $10.33, valued at
$2.1k
|
|
| 03/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/30/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/20/2019 |
4
| CROWELL GAYLE A (Director) has filed a Form 4 on Hercules Capital, Inc.|
Txns:
| Granted 118 shares
@ $12.74, valued at
$1.5k
|
|
| 05/22/2019 |
4
| CROWELL GAYLE A (Director) has filed a Form 4 on Hercules Capital, Inc.|
Txns:
| Granted 108 shares
@ $13.13, valued at
$1.4k
|
|
| 03/28/2019 |
4
| CROWELL GAYLE A (Director) has filed a Form 4 on Hercules Capital, Inc.|
Txns:
| Granted 4,315 shares
@ $12.44, valued at
$53.7k
|
|
| 03/06/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|